Abstract
Failed back surgery syndrome (FBBS†) is characterized by chronic pain that persists following spine surgery. In this review, we discuss the use of spinal cord stimulation (SCS) for FBBS treatment and how the clinical use of SCS may be influenced by private manufacturers. While SCS therapy can be promising for the appropriate patient, there remain knowledge gaps in understanding the full potential of SCS technology for delivering optimal therapeutic benefit. We caution that the use of SCS without a complete understanding of the technology may create exploitative situations that private manufacturers can capitalize on while subjecting patients to potentially unnecessary health and financial burdens.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 323-331 |
| Number of pages | 9 |
| Journal | Yale Journal of Biology and Medicine |
| Volume | 91 |
| Issue number | 3 |
| State | Published - Sep 1 2018 |
Fingerprint
Keywords
- Chronic pain
- Failed back surgery syndrome
- Neurosurgery
- Spinal cord stimulation
- Spine surgery
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Cite this
Two surgeries do not always make a right : Spinal cord stimulation for failed back surgery syndrome. / Duy, Phan Q.; Anderson, William S.
In: Yale Journal of Biology and Medicine, Vol. 91, No. 3, 01.09.2018, p. 323-331.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Two surgeries do not always make a right
T2 - Spinal cord stimulation for failed back surgery syndrome
AU - Duy, Phan Q.
AU - Anderson, William S
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Failed back surgery syndrome (FBBS†) is characterized by chronic pain that persists following spine surgery. In this review, we discuss the use of spinal cord stimulation (SCS) for FBBS treatment and how the clinical use of SCS may be influenced by private manufacturers. While SCS therapy can be promising for the appropriate patient, there remain knowledge gaps in understanding the full potential of SCS technology for delivering optimal therapeutic benefit. We caution that the use of SCS without a complete understanding of the technology may create exploitative situations that private manufacturers can capitalize on while subjecting patients to potentially unnecessary health and financial burdens.
AB - Failed back surgery syndrome (FBBS†) is characterized by chronic pain that persists following spine surgery. In this review, we discuss the use of spinal cord stimulation (SCS) for FBBS treatment and how the clinical use of SCS may be influenced by private manufacturers. While SCS therapy can be promising for the appropriate patient, there remain knowledge gaps in understanding the full potential of SCS technology for delivering optimal therapeutic benefit. We caution that the use of SCS without a complete understanding of the technology may create exploitative situations that private manufacturers can capitalize on while subjecting patients to potentially unnecessary health and financial burdens.
KW - Chronic pain
KW - Failed back surgery syndrome
KW - Neurosurgery
KW - Spinal cord stimulation
KW - Spine surgery
UR - http://www.scopus.com/inward/record.url?scp=85054088543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054088543&partnerID=8YFLogxK
M3 - Review article
C2 - 30258319
AN - SCOPUS:85054088543
VL - 91
SP - 323
EP - 331
JO - Yale Journal of Biology and Medicine
JF - Yale Journal of Biology and Medicine
SN - 0044-0086
IS - 3
ER -